1. Home
  2. ARTV vs CCLD Comparison

ARTV vs CCLD Comparison

Compare ARTV & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • CCLD
  • Stock Information
  • Founded
  • ARTV 2019
  • CCLD 1999
  • Country
  • ARTV United States
  • CCLD United States
  • Employees
  • ARTV N/A
  • CCLD N/A
  • Industry
  • ARTV
  • CCLD Computer Software: Prepackaged Software
  • Sector
  • ARTV
  • CCLD Technology
  • Exchange
  • ARTV NYSE
  • CCLD Nasdaq
  • Market Cap
  • ARTV 61.9M
  • CCLD 52.5M
  • IPO Year
  • ARTV 2024
  • CCLD 2014
  • Fundamental
  • Price
  • ARTV $1.93
  • CCLD $2.02
  • Analyst Decision
  • ARTV Strong Buy
  • CCLD Buy
  • Analyst Count
  • ARTV 7
  • CCLD 2
  • Target Price
  • ARTV $19.17
  • CCLD $3.00
  • AVG Volume (30 Days)
  • ARTV 147.5K
  • CCLD 616.6K
  • Earning Date
  • ARTV 05-08-2025
  • CCLD 05-06-2025
  • Dividend Yield
  • ARTV N/A
  • CCLD N/A
  • EPS Growth
  • ARTV N/A
  • CCLD N/A
  • EPS
  • ARTV N/A
  • CCLD N/A
  • Revenue
  • ARTV N/A
  • CCLD $112,507,000.00
  • Revenue This Year
  • ARTV N/A
  • CCLD $2.74
  • Revenue Next Year
  • ARTV N/A
  • CCLD $7.52
  • P/E Ratio
  • ARTV N/A
  • CCLD N/A
  • Revenue Growth
  • ARTV N/A
  • CCLD N/A
  • 52 Week Low
  • ARTV $1.78
  • CCLD $1.14
  • 52 Week High
  • ARTV $17.31
  • CCLD $4.84
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • CCLD 54.09
  • Support Level
  • ARTV N/A
  • CCLD $1.96
  • Resistance Level
  • ARTV N/A
  • CCLD $2.14
  • Average True Range (ATR)
  • ARTV 0.00
  • CCLD 0.11
  • MACD
  • ARTV 0.00
  • CCLD -0.01
  • Stochastic Oscillator
  • ARTV 0.00
  • CCLD 29.18

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About CCLD CareCloud Inc.

CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

Share on Social Networks: